Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jun 5 2023 | Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care Industry News In The News Industry Read More Jun 5 2023 | INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Industry News In The News Industry Read More Jun 2 2023 | HFSA Announces New Officer and Board of Directors Positions For 2023 and Beyond HFSA News Leadership Read More Jun 1 2023 | Registration is Open for the HFSA Annual Scientific Meeting 2023 HFSA News Annual Scientific Meeting Professional Development Read More Jun 1 2023 | Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page Next › Last page Last »
Jun 5 2023 | Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care Industry News In The News Industry Read More
Jun 5 2023 | INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Industry News In The News Industry Read More
Jun 2 2023 | HFSA Announces New Officer and Board of Directors Positions For 2023 and Beyond HFSA News Leadership Read More
Jun 1 2023 | Registration is Open for the HFSA Annual Scientific Meeting 2023 HFSA News Annual Scientific Meeting Professional Development Read More
Jun 1 2023 | Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure Industry News In The News Industry Read More
